Pre-order Enquiry
Request Free Sample
Global Methotrexate Market Growth 2019-2024
SKU ID : LPI-13806573 | Publishing Date : 01-Feb-2019 | No. of pages : 139
Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.
Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis.
The technical barriers of methotrexate are not high, and the methotrexate enterprise concentrate in China, USA, Australia, and the relative large companies include Teva Pharmaceutical Industries, Qualitestrx (DAVA Pharmaceuticals), Pfizer (Hospira), Roxane Laboratories, Sine, Maoxiang, LingNan Pharmaceutical and others.
Methotrexate is a drug used to treat several forms of cancer as well as some autoimmune system diseases. In 2014, methotrexate for breast, head and neck, lung, stomach, and esophagus cancers occupies more than 70% share of total amount. As the demand increases rapidly with higher spending propensity, the increased consumption is expected to continue during the remaining years of the forecast period of 2016-2021. Methotrexate industry will usher in a stable growth space.
According to this study, over the next five years the Methotrexate market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Methotrexate business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Methotrexate market by product type, application, key manufacturers and key regions and countries.
This study considers the Methotrexate value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Methotrexate for Injection
Methotrexate Tablets
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Used for Cancers
Used for Rheumatoid Arthritis
Used for Other Diseases
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Teva Pharmaceutical Industries
Qualitestrx(DAVA Pharmaceuticals)
Pfizer (Hospira)
Roxane Laboratories
Sine
Maoxiang
LingNan Pharmaceutical
Powerdone
Huiyu
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Methotrexate consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Methotrexate market by identifying its various subsegments.
Focuses on the key global Methotrexate manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Methotrexate with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Methotrexate submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis.
The technical barriers of methotrexate are not high, and the methotrexate enterprise concentrate in China, USA, Australia, and the relative large companies include Teva Pharmaceutical Industries, Qualitestrx (DAVA Pharmaceuticals), Pfizer (Hospira), Roxane Laboratories, Sine, Maoxiang, LingNan Pharmaceutical and others.
Methotrexate is a drug used to treat several forms of cancer as well as some autoimmune system diseases. In 2014, methotrexate for breast, head and neck, lung, stomach, and esophagus cancers occupies more than 70% share of total amount. As the demand increases rapidly with higher spending propensity, the increased consumption is expected to continue during the remaining years of the forecast period of 2016-2021. Methotrexate industry will usher in a stable growth space.
According to this study, over the next five years the Methotrexate market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Methotrexate business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Methotrexate market by product type, application, key manufacturers and key regions and countries.
This study considers the Methotrexate value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Methotrexate for Injection
Methotrexate Tablets
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Used for Cancers
Used for Rheumatoid Arthritis
Used for Other Diseases
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Teva Pharmaceutical Industries
Qualitestrx(DAVA Pharmaceuticals)
Pfizer (Hospira)
Roxane Laboratories
Sine
Maoxiang
LingNan Pharmaceutical
Powerdone
Huiyu
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Methotrexate consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Methotrexate market by identifying its various subsegments.
Focuses on the key global Methotrexate manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Methotrexate with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Methotrexate submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Request Sample
Request Discount
